Alfuzosin Hydrochloride Tablet, Extended Release
Product Images NDC 76282-302

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alfuzosin Hydrochloride (NDC 76282-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alf4 (Alf4)

FDA Label Image

Alf8 (Alf8)

This is a description of a medication called Alfuzosin HCI Extended-Release Tablets, USP. The medication comes in a bottle that contains 100 tablets. Each tablet has 10mg of Alfuzosin Hydrochloride, USP. The package insert contains dosage information, and the medication should be stored in a light-resistant container at a temperature of 20°C to 25°C. It is manufactured by InvaGen Pharmaceuticals for Exelan Pharmaceuticals.*

FDA Label Image

Dia1 (Dia1)

FDA Label Image

Dia10 (Dia10)

FDA Label Image

Dia11 (Dia11)

This appears to be a comparison of two groups - one treated with a placebo (N=150) and the other treated with Alfuzosin HCl (N=151) over 28 days. However, the purpose or outcome of the study is not clear from the given text. The notation "NS p>0.08" may indicate that there was not a statistically significant difference between the two groups, but this is unclear without additional context.*

FDA Label Image

Dia6 (Dia6)

FDA Label Image

Dia7 (Dia7)

FDA Label Image

Dia8 (Dia8)

FDA Label Image

Dia9 (Dia9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.